-
Something wrong with this record ?
Positive Modulators of the N-Methyl-d-aspartate Receptor: Structure-Activity Relationship Study of Steroidal 3-Hemiesters
B. Krausova, B. Slavikova, M. Nekardova, P. Hubalkova, V. Vyklicky, H. Chodounska, L. Vyklicky, E. Kudova,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NV15-29370A
MZ0
CEP Register
- MeSH
- Allosteric Regulation MeSH
- HEK293 Cells MeSH
- Protein Conformation MeSH
- Humans MeSH
- Membrane Transport Modulators chemistry pharmacology MeSH
- Models, Molecular MeSH
- Molecular Structure MeSH
- Pregnenolone pharmacology MeSH
- Receptors, N-Methyl-D-Aspartate antagonists & inhibitors metabolism MeSH
- Steroids chemistry pharmacology MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Here, we report the synthesis of pregn-5-ene and androst-5-ene dicarboxylic acid esters and explore the structure-activity relationship (SAR) for their modulation of N-methyl-d-aspartate receptors (NMDARs). All compounds were positive modulators of recombinant GluN1/GluN2B receptors (EC50 varying from 1.8 to 151.4 μM and Emax varying from 48% to 452%). Moreover, 10 compounds were found to be more potent GluN1/GluN2B receptor modulators than endogenous pregnenolone sulfate (EC50 = 21.7 μM). The SAR study revealed a relationship between the length of the residues at carbon C-3 of the steroid molecule and the positive modulatory effect at GluN1/GluN2B receptors for various D-ring modifications. A selected compound, 20-oxo-pregnenolone hemiadipate, potentiated native NMDARs to a similar extent as GluN1/GluN2A-D receptors and inhibited AMPARs and GABAAR responses. These results provide a unique opportunity for the development of new steroid based drugs with potential use in the treatment of neuropsychiatric disorders involving hypofunction of NMDARs.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028457
- 003
- CZ-PrNML
- 005
- 20201031115452.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.8b00255 $2 doi
- 035 __
- $a (PubMed)29708744
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krausova, Barbora $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic.
- 245 10
- $a Positive Modulators of the N-Methyl-d-aspartate Receptor: Structure-Activity Relationship Study of Steroidal 3-Hemiesters / $c B. Krausova, B. Slavikova, M. Nekardova, P. Hubalkova, V. Vyklicky, H. Chodounska, L. Vyklicky, E. Kudova,
- 520 9_
- $a Here, we report the synthesis of pregn-5-ene and androst-5-ene dicarboxylic acid esters and explore the structure-activity relationship (SAR) for their modulation of N-methyl-d-aspartate receptors (NMDARs). All compounds were positive modulators of recombinant GluN1/GluN2B receptors (EC50 varying from 1.8 to 151.4 μM and Emax varying from 48% to 452%). Moreover, 10 compounds were found to be more potent GluN1/GluN2B receptor modulators than endogenous pregnenolone sulfate (EC50 = 21.7 μM). The SAR study revealed a relationship between the length of the residues at carbon C-3 of the steroid molecule and the positive modulatory effect at GluN1/GluN2B receptors for various D-ring modifications. A selected compound, 20-oxo-pregnenolone hemiadipate, potentiated native NMDARs to a similar extent as GluN1/GluN2A-D receptors and inhibited AMPARs and GABAAR responses. These results provide a unique opportunity for the development of new steroid based drugs with potential use in the treatment of neuropsychiatric disorders involving hypofunction of NMDARs.
- 650 _2
- $a alosterická regulace $7 D000494
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a modulátory membránového transportu $x chemie $x farmakologie $7 D049990
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a pregnenolon $x farmakologie $7 D011284
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a receptory N-methyl-D-aspartátu $x antagonisté a inhibitory $x metabolismus $7 D016194
- 650 _2
- $a steroidy $x chemie $x farmakologie $7 D013256
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Slavikova, Barbora $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic.
- 700 1_
- $a Nekardova, Michaela $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic. Faculty of Mathematics and Physics , Charles University in Prague , Ke Karlovu 3 , Prague 2, 121 16 , Czech Republic.
- 700 1_
- $a Hubalkova, Pavla $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic. Third Faculty of Medicine , Charles University in Prague , Ruska 87 , Prague 10, 100 00 , Czech Republic.
- 700 1_
- $a Vyklicky, Vojtech $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic.
- 700 1_
- $a Chodounska, Hana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic.
- 700 1_
- $a Vyklicky, Ladislav $u Institute of Physiology of the Czech Academy of Sciences , Videnska 1083 , Prague 4, 142 20 , Czech Republic.
- 700 1_
- $a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nam. 2 , Prague 6, 166 10 , Czech Republic.
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 61, č. 10 (2018), s. 4505-4516
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29708744 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20201031115450 $b ABA008
- 999 __
- $a ok $b bmc $g 1433606 $s 1066917
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 61 $c 10 $d 4505-4516 $e 20180504 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- GRA __
- $a NV15-29370A $p MZ0
- LZP __
- $a Pubmed-20190813